Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 5
2003 3
2004 3
2005 3
2006 3
2007 1
2008 4
2009 4
2010 5
2011 8
2012 7
2013 11
2014 6
2015 8
2016 6
2017 3
2018 12
2019 5
2020 12
2021 3
Text availability
Article attribute
Article type
Publication date

Search Results

95 results
Results by year
Filters applied: . Clear all
Page 1
Mechanisms of Resistance to Anti-CD38 Daratumumab in Multiple Myeloma.
Saltarella I, Desantis V, Melaccio A, Solimando AG, Lamanuzzi A, Ria R, Storlazzi CT, Mariggiò MA, Vacca A, Frassanito MA. Saltarella I, et al. Among authors: ria r. Cells. 2020 Jan 9;9(1):167. doi: 10.3390/cells9010167. Cells. 2020. PMID: 31936617 Free PMC article. Review.
High-Risk Multiple Myeloma: Integrated Clinical and Omics Approach Dissects the Neoplastic Clone and the Tumor Microenvironment.
Solimando AG, Da Vià MC, Cicco S, Leone P, Di Lernia G, Giannico D, Desantis V, Frassanito MA, Morizio A, Delgado Tascon J, Melaccio A, Saltarella I, Ranieri G, Ria R, Rasche L, Kortüm KM, Beilhack A, Racanelli V, Vacca A, Einsele H. Solimando AG, et al. Among authors: ria r. J Clin Med. 2019 Jul 9;8(7):997. doi: 10.3390/jcm8070997. J Clin Med. 2019. PMID: 31323969 Free PMC article. Review.
Bone Marrow Stromal Cells-Induced Drug Resistance in Multiple Myeloma.
Ria R, Vacca A. Ria R, et al. Int J Mol Sci. 2020 Jan 17;21(2):613. doi: 10.3390/ijms21020613. Int J Mol Sci. 2020. PMID: 31963513 Free PMC article. Review.
Bortezomib Treatment Modulates Autophagy in Multiple Myeloma.
Di Lernia G, Leone P, Solimando AG, Buonavoglia A, Saltarella I, Ria R, Ditonno P, Silvestris N, Crudele L, Vacca A, Racanelli V. Di Lernia G, et al. Among authors: ria r. J Clin Med. 2020 Feb 18;9(2):552. doi: 10.3390/jcm9020552. J Clin Med. 2020. PMID: 32085480 Free PMC article.
Halting the vicious cycle within the multiple myeloma ecosystem: blocking JAM-A on bone marrow endothelial cells restores the angiogenic homeostasis and suppresses tumor progression.
Solimando AG, Da Vià MC, Leone P, Borrelli P, Croci GA, Tabares P, Brandl A, Di Lernia G, Bianchi FP, Tafuri S, Steinbrunn T, Balduini A, Melaccio A, De Summa S, Argentiero A, Rauert-Wunderlich H, Frassanito MA, Ditonno P, Henke E, Klapper W, Ria R, Terragna C, Rasche L, Rosenwald A, Kortüm KM, Cavo M, Ribatti D, Racanelli V, Einsele H, Vacca A, Beilhack A. Solimando AG, et al. Among authors: ria r. Haematologica. 2020 Apr 30:haematol.2019.239913. doi: 10.3324/haematol.2019.239913. Online ahead of print. Haematologica. 2020. PMID: 32354870 Free article.
Anti-VEGF Drugs in the Treatment of Multiple Myeloma Patients.
Ria R, Melaccio A, Racanelli V, Vacca A. Ria R, et al. J Clin Med. 2020 Jun 6;9(6):1765. doi: 10.3390/jcm9061765. J Clin Med. 2020. PMID: 32517267 Free PMC article. Review.
Chemotherapy plus lenalidomide versus autologous transplantation, followed by lenalidomide plus prednisone versus lenalidomide maintenance, in patients with multiple myeloma: a randomised, multicentre, phase 3 trial.
Gay F, Oliva S, Petrucci MT, Conticello C, Catalano L, Corradini P, Siniscalchi A, Magarotto V, Pour L, Carella A, Malfitano A, Petrò D, Evangelista A, Spada S, Pescosta N, Omedè P, Campbell P, Liberati AM, Offidani M, Ria R, Pulini S, Patriarca F, Hajek R, Spencer A, Boccadoro M, Palumbo A. Gay F, et al. Among authors: ria r. Lancet Oncol. 2015 Dec;16(16):1617-29. doi: 10.1016/S1470-2045(15)00389-7. Epub 2015 Nov 17. Lancet Oncol. 2015. PMID: 26596670 Free article. Clinical Trial.
Elotuzumab, lenalidomide, and dexamethasone as salvage therapy for patients with multiple myeloma: Italian, multicenter, retrospective clinical experience with 300 cases outside of controlled clinical trials.
Gentile M, Specchia G, Derudas D, Galli M, Botta C, Rocco S, Conticello C, Califano C, Giuliani N, Mangiacavalli S, Attingenti E, Lombardo A, Brunori M, Rossi E, Antonioli E, Ria R, Zambello R, Di Renzo N, Mele G, Marcacci G, Musto P, Capalbo S, Cascavilla N, Cerchione C, Belotti A, Criscuolo C, Uccello G, Curci P, Vigna E, Fraticelli V, Vincelli D, Bonalumi A, Siniscalchi A, Stocchi R, Martino M, Ballanti S, Gangemi D, Gagliardi A, Gamberi B, Pompa A, Recchia AG, Tripepi G, Pitino A, Frigeri F, Consoli U, Bringhen S, Zamagni E, Patriarca F, De Stefano V, Di Raimondo F, Palmieri S, Petrucci MT, Offidani M, Boccadoro M, Cavo M, Morabito F. Gentile M, et al. Among authors: ria r. Haematologica. 2021 Jan 1;106(1):291-294. doi: 10.3324/haematol.2019.241513. Haematologica. 2021. PMID: 32107338 Free PMC article. No abstract available.
Heavy-Chain Diseases and Myeloma-Associated Fanconi Syndrome: an Update.
Ria R, Dammacco F, Vacca A. Ria R, et al. Mediterr J Hematol Infect Dis. 2018 Jan 1;10(1):e2018011. doi: 10.4084/MJHID.2018.011. eCollection 2018. Mediterr J Hematol Infect Dis. 2018. PMID: 29326807 Free PMC article. Review.
Response to letter: "Effect of thyroidectomy on circulating angiogenic cytokines in papillary thyroid carcinoma and benign goiter: Potential for new biomarkers?".
Prete FP, Ria R, Gurrado A, Testini M. Prete FP, et al. Among authors: ria r. Surgery. 2020 Dec 5:S0039-6060(20)30736-4. doi: 10.1016/j.surg.2020.10.030. Online ahead of print. Surgery. 2020. PMID: 33293031 No abstract available.
95 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback